Navigation Links
Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2011 Financial Results on November 3, 2011
Date:10/27/2011

SAN DIEGO, Oct. 27, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today announced that it will release its third quarter ended September 30, 2011 financial results on Thursday, November 3, 2011.

Cadence management will host a conference call and live webcast to discuss the financial results on Thursday, November 3, 2011 at 1:30 pm Pacific Time (4:30 pm Eastern Time). Interested investors may participate in the conference call by dialing (877) 303-9145 (domestic) or (760) 536-5203 (international).  To access the webcast, please visit the company's website at www.cadencepharm.com and go to the Investor Relations page.  A replay of the webcast will be available approximately two hours after the call and remain available on the company's website until the next quarterly financial results call.

About Cadence Pharmaceuticals, Inc.Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting. In January 2011, Cadence commercially launched OFIRMEV™ (acetaminophen) injection, an intravenous formulation of acetaminophen, in the U.S.  For more information about Cadence, please visit www.cadencepharm.com.Contacts:

William R. LaRueSVP & Chief Financial OfficerCadence Pharmaceuticals, Inc.858-436-1400
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cadence Pharmaceuticals to Present at Three Investment Conferences During the Month of September 2011
2. Cadence Pharmaceuticals Reports Second Quarter 2011 Financial Results
3. Cadence Pharmaceuticals to Present at Two Investment Conferences During the Month of August 2011
4. Cadence Pharmaceuticals Reaffirms FDA-Approved Dosing Recommendations for OFIRMEV® (acetaminophen) Injection
5. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Jefferies 2011 Global Healthcare Conference on June 9, 2011
6. Cadence, Inc. Announces Major Expansion
7. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2011 Financial Results on May 5, 2011
8. Cadence Pharmaceuticals CEO Ted Schroeder to Present at Three Investment Conferences During the Month of May 2011
9. Cadence, Inc. Expands Executive Team
10. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
11. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Cowen and Company 31st Annual Health Care Conference in Boston on March 9, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... 20, 2017 According to a new market research ... powder), Device Type (Metered dose, Dry Powder, Nebulizer)), Canister (Plain, Coated), End ... The market is projected to reach USD 52.37 Billion by 2021 from ... forecast period. Continue Reading ... ...
(Date:2/20/2017)... -- Acute, Chronic and Prophylaxis GVHD The global ... of 7% from 2016-2021 and CAGR of 3% from 2021-2027. The market ... 2027. The market is estimated at $0.36bn in 2016, $0.51bn in 2021, ... How ... can exploit the future business opportunities emerging in this sector. ...
(Date:2/19/2017)... and ORLANDO, Fla. , ... NKTR ) today announced that positive Phase 1 ... patients with renal cell carcinoma (RCC) were presented at ... designed to expand specific cancer-fighting T cells and Natural ... and increase expression of PD-1 on these immune cells.  ...
Breaking Medicine Technology:
(Date:2/19/2017)... ... ... The Citadel’s new Swain Department of Nursing , along with its ... Joseph was engaged by the college as a consultant to help build the curriculum ... nation-wide search, she was selected to head the department as nurse administrator, assuming the ...
(Date:2/18/2017)... ... February 17, 2017 , ... ... **FDAnews Free Webinar**, March 1, 2017 — 1:30 p.m. – 2:30 p.m. ... burden? Pay dividends in enhanced and predictable product performance? Streamline processes resulting ...
(Date:2/18/2017)... ... 18, 2017 , ... ProParagraph Fashion Volume 2 features 30 ... Fashion Volume 2 for all multi-line FCPX project needs. Great for website ... choose from hand-crafted trend-setting designs with smooth animations that will add stylistic flare ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... allow for the electronic prescribing of controlled and non-controlled substances plus the ability ... of pharmacies in the United States now accept electronic prescriptions, according to the ...
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... ... organizations, has been named a finalist in the 8th Annual DecisionHealth Platinum Awards ... healthcare delivery system. Qualis Health’s work is recognized across multiple award categories, highlighting ...
Breaking Medicine News(10 mins):